Breaking News Instant updates and real-time market news.

SPPI

Spectrum

$20.36

-0.64 (-3.05%)

16:01
08/09/18
08/09
16:01
08/09/18
16:01

Spectrum reports Q2 EPS (21c), consensus (21c)

Reports Q2 revenue $24.2M, consensus $27.58M.

  • 04

    Sep

SPPI Spectrum
$20.36

-0.64 (-3.05%)

02/05/18
HCWC
02/05/18
NO CHANGE
Target $33
HCWC
Buy
Spectrum price target raised to $33 from $29 at H.C. Wainwright
H.C. Wainwright analyst Edward White raised his price target for Spectrum Pharmaceuticals to $33 after the company's This Advance Phase 3 study met the primary efficacy endpoint of non-inferiority in duration of severe neutropenia between Rolontis and Neulasta. The analyst is encouraged by the positive top-line data and looks forward to the full data set. He continues to believe Rolontis has blockbuster potential and projects revenue of $650M in 2024. White keeps a Buy rating Spectrum.
03/13/18
HCWC
03/13/18
NO CHANGE
Target $33
HCWC
Buy
Spectrum recent weakness a buying opportunity, says H.C. Wainwright
H.C. Wainwright analyst Edward White views the recent pullback in shares of Spectrum Pharmaceuticals as a buying opportunity. The next big clinical update for poziotinib is expected in the second half of 2018, most likely at the World Conference on Lung Cancer, White tells investors in a research note. He believes the recent stock price weakness is due to some investors believing that something is wrong with the study since data will not be at ASCO. The analyst, however, reiterates that he never expected to see data at ASCO. He continues to believe the MD Anderson study is proceeding as expected and keeps a Buy rating on Spectrum with a $33 price target.
04/10/18
RILY
04/10/18
NO CHANGE
Target $26
RILY
Buy
B. Riley FBR says Spectrum likely has one more meeting before poziotinib filing
After Spectrum reported that MD Anderson's Phase 2 study of poziotinib in patients with advanced nonsmall cell lung cancer with EGFR exon 20 mutations has fully enrolled its initial 30- patient cohort and updated on the initial 11 patients, B. Riley FBR analyst David Buck said he expects one more FDA meeting before a likely filing in 2018. He reiterates a Buy rating and $26 price target on Spectrum shares.
06/27/18
RILY
06/27/18
NO CHANGE
Target $26
RILY
Buy
Spectrum takeover report 'plausible,' says B. Riley FBR
Following a report from Bloomberg yesterday that Spectrum Pharmaceuticals is exploring options including a sale of the business amid takeover interest from other drugmakers, B. RIley FBR analyst David Buck told investors in a research note that while he has no confirmation of any takeover interest or sale process, he sees the report as "plausible." Buck, who reiterated a Buy rating, says that he continues to see his $26 per share target based on DCF and 2022E earnings power as "reasonable." Aide from any actual news on a potential transaction or sales process that gets confirmed, he expects further news flow on pipeline drug Rolontis, including a June 29 Spectrum-sponsored conference call and an expected presentation of additional poziotinib data at the World Lung Conference.

TODAY'S FREE FLY STORIES

BBY

Best Buy

$64.08

1.89 (3.04%)

11:10
11/20/18
11/20
11:10
11/20/18
11:10
Options
Best Buy puts active as shares see relative strength »

Best Buy puts active as…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Nov

  • 05

    Dec

AAPL

Apple

$179.47

-6.33 (-3.41%)

, AMZN

Amazon.com

$1,505.00

-6.67 (-0.44%)

11:06
11/20/18
11/20
11:06
11/20/18
11:06
Hot Stocks
White House asks for comment on possible emerging technology export restrictions »

In an advance notice of…

AAPL

Apple

$179.47

-6.33 (-3.41%)

AMZN

Amazon.com

$1,505.00

-6.67 (-0.44%)

GOOGL

Alphabet Class A

$1,027.00

0.77 (0.08%)

GOOG

Alphabet

$1,018.84

-0.16 (-0.02%)

IBM

IBM

$118.62

-1.75 (-1.45%)

FB

Facebook

$133.10

1.48 (1.12%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Nov

  • 28

    Nov

  • 04

    Dec

  • 04

    Dec

  • 03

    Mar

AMZN

Amazon.com

$1,501.81

-9.86 (-0.65%)

11:04
11/20/18
11/20
11:04
11/20/18
11:04
Technical Analysis
Technical Take: Amazon.com hits highs of the session »

The shares of Amazon.com…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Nov

  • 04

    Dec

OKTA

Okta

$47.47

-1.17 (-2.41%)

11:03
11/20/18
11/20
11:03
11/20/18
11:03
Hot Stocks
Okta continues expansion of API gateway partner ecosystem »

Okta announced its…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Dec

  • 09

    Jan

AJG

Arthur J. Gallagher

$77.73

-0.6 (-0.77%)

11:02
11/20/18
11/20
11:02
11/20/18
11:02
Hot Stocks
Arthur J. Gallagher acquires JP Tech Insurance Services, terms not disclosed »

Arthur J. Gallagher &…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DNR

Denbury Resources

$2.29

-0.155 (-6.34%)

11:00
11/20/18
11/20
11:00
11/20/18
11:00
Options
2-strike put buyers in Denbury Resources as shares drop 9.3% »

2-strike put buyers in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

11:00
11/20/18
11/20
11:00
11/20/18
11:00
General news
Atlanta Fed's Q4 GDPNow estimate was cut to 2.5% »

Atlanta Fed's Q4…

DB

Deutsche Bank

$9.38

-0.39 (-3.99%)

, DNSKY

Danske Bank

$0.00

(0.00%)

10:56
11/20/18
11/20
10:56
11/20/18
10:56
Periodicals
Deutsche finds $150B of suspicious flows tied to Danske, WSJ reports »

Deutsche Bank's (DB)…

DB

Deutsche Bank

$9.38

-0.39 (-3.99%)

DNSKY

Danske Bank

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NURO

NeuroMetrix

$0.98

-0.02 (-2.00%)

10:53
11/20/18
11/20
10:53
11/20/18
10:53
Hot Stocks
NeuroMetrix issued new U.S. patent for Quell wearable technology »

NeuroMetrix announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 04

    Dec

X

U.S. Steel

$26.42

-0.86 (-3.15%)

10:50
11/20/18
11/20
10:50
11/20/18
10:50
Options
US Steel sees put buying as shares drop 4.4% »

US Steel sees put buying…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SNAP

Snap

$5.98

-0.075 (-1.24%)

10:47
11/20/18
11/20
10:47
11/20/18
10:47
Periodicals
Snap soon to debut new, higher-priced Spectacles with two cameras, Cheddar says »

Snap is looking to debut…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Nov

  • 28

    Nov

TLSA

Tiziana Therapeutics

$0.00

(0.00%)

10:45
11/20/18
11/20
10:45
11/20/18
10:45
Syndicate
Tiziana Therapeutics opens at $10.50, IPO priced at $9.90 »

Tiziana Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Nov

BE

Bloom Energy

$14.00

-0.5 (-3.45%)

10:45
11/20/18
11/20
10:45
11/20/18
10:45
Conference/Events
Bloom Energy has a conference call hosted by JPMorgan »

JPMorgan Analyst Coster…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Nov

  • 05

    Dec

SPX

S&P 500

$0.00

(0.00%)

, SPY

SPDR S&P 500 ETF Trust

$264.96

-4.32 (-1.60%)

10:42
11/20/18
11/20
10:42
11/20/18
10:42
Technical Analysis
Technical Take: SPDR S&P 500 ETF breaks back above $265 »

The SPDR S&P 500 ETF…

SPX

S&P 500

$0.00

(0.00%)

SPY

SPDR S&P 500 ETF Trust

$264.96

-4.32 (-1.60%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MS

Morgan Stanley

$42.91

-1.51 (-3.40%)

10:40
11/20/18
11/20
10:40
11/20/18
10:40
Options
Put spreads in Morgan Stanley weekly options as shares fall to 52-week lows »

Put spreads in Morgan…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AMZN

Amazon.com

$1,478.00

-33.67 (-2.23%)

10:38
11/20/18
11/20
10:38
11/20/18
10:38
Technical Analysis
Technical Take: Amazon.com breaks back above $1500 »

The stock saw a deep low…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Nov

  • 04

    Dec

BBY

Best Buy

$63.02

0.83 (1.33%)

10:31
11/20/18
11/20
10:31
11/20/18
10:31
Hot Stocks
Best Buy expects calendar shift to have positive impact of approx. 50bps in Q4 »

CFO Corie Barry says…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Nov

  • 05

    Dec

BAC

Bank of America

$26.99

-0.77 (-2.77%)

10:30
11/20/18
11/20
10:30
11/20/18
10:30
Options
Far downside puts opened in BofA »

Far downside puts opened…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Feb

NVDA

Nvidia

$142.45

-2.21 (-1.53%)

10:23
11/20/18
11/20
10:23
11/20/18
10:23
Hot Stocks
Nvidia turns positive as Citron sees opportunity to buy »

Shares of Nvidia, which…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Nov

  • 10

    Dec

WMT

Walmart

$94.27

-2.53 (-2.61%)

10:23
11/20/18
11/20
10:23
11/20/18
10:23
Downgrade
Walmart rating change  »

Walmart downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BBY

Best Buy

$64.10

1.91 (3.07%)

10:21
11/20/18
11/20
10:21
11/20/18
10:21
Hot Stocks
Best Buy sees opportunities in connected health space »

CEO Hubert Joly says…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Nov

  • 05

    Dec

FXI

iShares China Large-Cap ETF

$40.19

-0.6 (-1.47%)

10:20
11/20/18
11/20
10:20
11/20/18
10:20
Options
Global selloff draws bullish vertical spread in China ETF »

Global selloff draws…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NVDA

Nvidia

$143.52

-1.14 (-0.79%)

10:20
11/20/18
11/20
10:20
11/20/18
10:20
Periodicals
Citron Research says buying Nvidia »

Citron Research tweeted:…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Nov

  • 10

    Dec

10:20
11/20/18
11/20
10:20
11/20/18
10:20
General news
U.S. credit ETFs are probing lows again »

U.S. credit ETFs are…

$NSD

NASDAQ Market Internals

$0.00

(0.00%)

10:17
11/20/18
11/20
10:17
11/20/18
10:17
Technical Analysis
NASDAQ market internals summary »

Volume is above average…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.